Skip to main content

Table 1 Comparison of baseline data among study groups before and after propensity score matching

From: Effects of health intervention program on cardiometabolic risk profiles from health evaluation center in Asian population: a longitudinal study and propensity analysis

 

Initial cohort before PSA matching (N = 2,660)

Cohort after PSA matching (N = 1004)

Variable

Non-intervention (n = 1,738)

Intervention (n = 922)

P a

Non-intervention (n = 502)

Intervention (n = 502)

P a

Demographical data

      

 Age, year

40.93 (10.31)

44.85 (8.6)

<0.001

44.52 (9.35)

44.81 (8.14)

0.609

 Male gender, %

65.4%

60.2%

0.008

62.9%

64.3%

0.646

Physiologic parameters

      

 Systolic blood pressure, mmHg

117.32(15.04)

116.68 (14.55)

0.293

117.03 (13.75)

117.57 (14.67)

0.549

 Diastolic blood pressure, mmHg

73.43 (9.81)

73.45 (9.84)

0.946

73.34 (9.24)

73.86 (9.77)

0.387

 Waist Circumference, cm

80.01 (10.18)

80.13 (9.59)

0.785

80.5 (9.3)

80.5 (9.8)

0.99

 Body mass index, kg/m2

23.48 (3.32)

23.47 (3.15)

0.936

23.61 (2.86)

23.66 (3.21)

0.772

Serum sugar profiles

      

 Fasting glucose, mg/dL

92.96 (13.83)

94.73 (15.76)

0.0033

94.22 (16.95)

94.22 (13.54)

1.000

 Post-prandial glucose, mg/dL

101.51 (27.92)

103.73 (30.92)

0.139

104.16 (33.06)

103.75 (28.91)

0.846

 HbA1c, %

5.43 (0.61)

5.53 (0.58)

0.048

5.41 (0.53)

5.51 (0.58)

0.063

Lipid Profiles

      

 Total cholesterol, mg/dL

186.84 (32.90)

192.51 (33.42)

<0.001

191.16 (31.98)

192.06 (33.85)

0.666

 HDL, mg/dL

54.07 (13.97)

56.10 (14.68)

0.006

55.42 (14.75)

55.76 (14.58)

0.713

 LDL, mg/dL

118.46 (30.45)

124.86 (32.10)

<0.001

121.74 (29.55)

123.03 (31.11)

0.500

 Triglyceride, mg/dL

110.05 (95.60)

115.96 (82.05)

0.151

112.83 (90.05)

113.45 (72.88)

0.917

Life style

      

 Smoking, %

11.0%

17.0%

<0.001

16.5%

17.3%

0.736

 Alcohol Consumption, %

7.7%

18.3%

<0.001

16.1%

15.7%

0.863

 Exercise, %

23.9%

48.2%

<0.001

43.6%

45.6%

0.526

Cardiometabolic Outcomes

      

 ATP III, number of MetS

1.28 (1.23)

1.49 (1.30)

<0.001

1.41 (1.27)

1.50 (1.27)

0.296

 FRS, unit

4.57 (4.65)

4.97 (4.77)

0.132

4.68 (4.50)

4.76 (4.37)

0.809

 eGFR, mL/min per 1.73 m2

86.05 (19.43)

84.30 (13.92)

0.028

83.51 (17.00)

83.88 (13.79)

0.704

  1. adenotes either independent-sample t-test for continuous variable or chi-square test for categorical variable
Back to article page

Health and Quality of Life Outcomes

ISSN: 1477-7525

Contact us